2024 Q2 Form 10-Q Financial Statement

#000142368924000039 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $674.0M $1.139B
YoY Change -19.28% 255.94%
Cost Of Revenue $698.0M $672.0M
YoY Change 32.7% 49.67%
Gross Profit -$24.00M $467.0M
YoY Change -107.77% -462.02%
Gross Profit Margin -3.56% 41.0%
Selling, General & Admin $15.00M $16.00M
YoY Change 7.14% 14.29%
% of Gross Profit 3.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $24.00M $24.00M
YoY Change 4.35% 9.09%
Operating Profit -$48.00M $443.0M
YoY Change -116.78% -393.38%
Interest Expense $698.0M $672.0M
YoY Change 32.7% 49.67%
% of Operating Profit 151.69%
Other Income/Expense, Net -$21.00M $497.0M
YoY Change -105.56% -1703.23%
Pretax Income -$48.00M $443.0M
YoY Change -116.78% -393.38%
Income Tax
% Of Pretax Income
Net Earnings -$80.00M $412.0M
YoY Change -131.37% -372.85%
Net Earnings / Revenue -11.87% 36.17%
Basic Earnings Per Share -$0.11 $0.59
Diluted Earnings Per Share -$0.11 $0.59
COMMON SHARES
Basic Shares Outstanding 726.9M shares 695.0M shares
Diluted Shares Outstanding 740.0M shares 704.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $530.0M $505.0M
YoY Change -25.98% -48.21%
Cash & Equivalents $530.0M $505.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $5.000M
Other Receivables $0.00
Total Short-Term Assets $530.0M $510.0M
YoY Change -38.66% -61.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $76.80B $69.10B
YoY Change 34.07% 11.56%
Other Assets $1.376B $1.368B
YoY Change 51.71% -26.61%
Total Long-Term Assets $79.16B $71.37B
YoY Change 32.69% 10.15%
TOTAL ASSETS
Total Short-Term Assets $530.0M $510.0M
Total Long-Term Assets $79.16B $71.37B
Total Assets $79.69B $71.88B
YoY Change 31.67% 8.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $370.0M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $70.20B $49.97B
YoY Change 67.02% 3.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.90B $50.73B
YoY Change 61.01% 3.45%
LONG-TERM LIABILITIES
Long-Term Debt $71.00M $76.00M
YoY Change -18.39% -17.39%
Other Long-Term Liabilities $64.00M $12.50B
YoY Change -99.25% 35.91%
Total Long-Term Liabilities $135.0M $12.57B
YoY Change -98.43% 35.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.90B $50.73B
Total Long-Term Liabilities $135.0M $12.57B
Total Liabilities $71.03B $63.30B
YoY Change 34.94% 8.54%
SHAREHOLDERS EQUITY
Retained Earnings -$8.338B -$7.990B
YoY Change 9.24% 4.12%
Common Stock $8.000M $7.000M
YoY Change 33.33% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.652B $8.578B
YoY Change
Total Liabilities & Shareholders Equity $79.69B $71.88B
YoY Change 31.67% 8.72%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$80.00M $412.0M
YoY Change -131.37% -372.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00M $20.00M
YoY Change -67.21% -23.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$7.061B $582.0M
YoY Change -232.18% -105.03%
Cash From Investing Activities -$7.061B $582.0M
YoY Change -232.18% -105.03%
FINANCING ACTIVITIES
Cash Dividend Paid $282.0M
YoY Change 18.49%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.114B -$500.0M
YoY Change -209.5% -104.15%
NET CHANGE
Cash From Operating Activities -20.00M $20.00M
Cash From Investing Activities -7.061B $582.0M
Cash From Financing Activities 7.114B -$500.0M
Net Change In Cash 33.00M $102.0M
YoY Change -102.71% -79.8%
FREE CASH FLOW
Cash From Operating Activities -$20.00M $20.00M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
8578000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-151000000 usd
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0486
CY2023Q4 agnc Weighted Average Yield Percentage
WeightedAverageYieldPercentage
0.0441
CY2023Q4 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
44000000 usd
CY2024Q1 agnc Transfers Between Hierarchy Levels
TransfersBetweenHierarchyLevels
no
CY2024Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-91000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-81000000 usd
CY2024Q1 agnc Unrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincomenet
Unrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincomenet
-471000000 usd
CY2023Q1 agnc Unrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincomenet
Unrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincomenet
594000000 usd
CY2024Q1 agnc Gainlossonderivativeinstrumentsandothersecuritiesnet
Gainlossonderivativeinstrumentsandothersecuritiesnet
1059000000 usd
CY2023Q1 agnc Gainlossonderivativeinstrumentsandothersecuritiesnet
Gainlossonderivativeinstrumentsandothersecuritiesnet
-544000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
497000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31000000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
16000000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
14000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
24000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
22000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
443000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-151000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
31000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
30000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
412000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-181000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
443000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-151000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-77000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
142000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
366000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
31000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
30000000 usd
CY2024Q1 agnc Comprehensive Income Available To Common Shareholders
ComprehensiveIncomeAvailableToCommonShareholders
335000000 usd
CY2023Q1 agnc Comprehensive Income Available To Common Shareholders
ComprehensiveIncomeAvailableToCommonShareholders
-39000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
702200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
579300000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
704200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
579300000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7870000000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
800000 shares
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
171000000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
30000000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
209000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7792000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8257000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
443000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-77000000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
900000 shares
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
241000000 usd
CY2024Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
31000000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
254000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
443000000 usd
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-37000000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-120000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-1000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-1000000 usd
CY2024Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-91000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-81000000 usd
CY2024Q1 agnc Netunrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincome
Netunrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincome
471000000 usd
CY2023Q1 agnc Netunrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincome
Netunrealizedgainlossoninvestmentsecuritiesmeasuredatfairvaluethroughnetincome
-594000000 usd
CY2024Q1 agnc Loss On Derivative Instruments And Trading Securities Net
LossOnDerivativeInstrumentsAndTradingSecuritiesNet
-1059000000 usd
CY2023Q1 agnc Loss On Derivative Instruments And Trading Securities Net
LossOnDerivativeInstrumentsAndTradingSecuritiesNet
544000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-797000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
42000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-759000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
69000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26000000 usd
CY2024Q1 us-gaap Payments To Acquire Mortgage Backed Securities Mbs Categorized As Available For Sale
PaymentsToAcquireMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
6337000000 usd
CY2023Q1 us-gaap Payments To Acquire Mortgage Backed Securities Mbs Categorized As Available For Sale
PaymentsToAcquireMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
7829000000 usd
CY2024Q1 agnc Payments To Acquire Non Agency Mortgage Backed Securities
PaymentsToAcquireNonAgencyMortgageBackedSecurities
84000000 usd
CY2023Q1 agnc Payments To Acquire Non Agency Mortgage Backed Securities
PaymentsToAcquireNonAgencyMortgageBackedSecurities
45000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
5060000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
1400000000 usd
CY2024Q1 agnc Proceedsfromsaleof Credit Risk Transferandnon Agencysecurities
ProceedsfromsaleofCreditRiskTransferandnonAgencysecurities
62000000 usd
CY2023Q1 agnc Proceedsfromsaleof Credit Risk Transferandnon Agencysecurities
ProceedsfromsaleofCreditRiskTransferandnonAgencysecurities
166000000 usd
CY2024Q1 agnc Proceeds From Principal Collection Of Mortgage Backed Securities Categorized As Available For Sale
ProceedsFromPrincipalCollectionOfMortgageBackedSecuritiesCategorizedAsAvailableForSale
1065000000 usd
CY2023Q1 agnc Proceeds From Principal Collection Of Mortgage Backed Securities Categorized As Available For Sale
ProceedsFromPrincipalCollectionOfMortgageBackedSecuritiesCategorizedAsAvailableForSale
855000000 usd
CY2024Q1 agnc Principalcollectionsoncreditrisktransferandnon Agencysecurities
PrincipalcollectionsoncreditrisktransferandnonAgencysecurities
12000000 usd
CY2023Q1 agnc Principalcollectionsoncreditrisktransferandnon Agencysecurities
PrincipalcollectionsoncreditrisktransferandnonAgencysecurities
25000000 usd
CY2024Q1 agnc Payments To Acquire Us Treasury Securities
PaymentsToAcquireUSTreasurySecurities
3387000000 usd
CY2023Q1 agnc Payments To Acquire Us Treasury Securities
PaymentsToAcquireUSTreasurySecurities
8243000000 usd
CY2024Q1 agnc Proceeds From Sale Of Us Treasury Securities
ProceedsFromSaleOfUSTreasurySecurities
4446000000 usd
CY2023Q1 agnc Proceeds From Sale Of Us Treasury Securities
ProceedsFromSaleOfUSTreasurySecurities
4329000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
-644000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
-2201000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-389000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
28000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
582000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11571000000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1140681000000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
705124000000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1141136000000 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
693002000000 usd
CY2024Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4000000 usd
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
5000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
241000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
171000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
282000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
238000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-500000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12050000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
102000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
505000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1771000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2334000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1873000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2839000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
505000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
975000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1368000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1864000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1873000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2839000000 usd
CY2024Q1 agnc Required Annual Distribution Of Taxable Net Income
RequiredAnnualDistributionOfTaxableNetIncome
0.90
CY2024Q1 agnc Intended Annual Distributionof Taxable Net Income
IntendedAnnualDistributionofTaxableNetIncome
1
CY2024Q1 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
59000000 usd
CY2023Q4 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
44000000 usd
CY2023Q4 agnc Available For Sale Securities Weighted Average Life Coupon Rate
AvailableForSaleSecuritiesWeightedAverageLifeCouponRate
0.0486
CY2023Q4 agnc Available For Sale Securities Weighted Average Life Yield
AvailableForSaleSecuritiesWeightedAverageLifeYield
0.0441
CY2024Q1 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
59000000 usd
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1540000000 usd
CY2024Q1 us-gaap Financial Instruments Sold Not Yet Purchased Us Government And Agency Obligations
FinancialInstrumentsSoldNotYetPurchasedUSGovernmentAndAgencyObligations
12115000000 usd
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The accompanying consolidated financial statements and related notes are unaudited and include the accounts of all our wholly-owned subsidiaries and variable interest entities for which we are the primary beneficiary. Significant intercompany accounts and transactions have been eliminated. The accompanying consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements included in our most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2023. </span></div>The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. In the opinion of management, all adjustments, consisting solely of normal recurring accruals, necessary for the fair presentation of consolidated financial statements for the interim period have been included. The current period’s results of operations are not necessarily indicative of results that ultimately may be achieved for the year.
CY2024Q1 agnc Total Agency Securities
TotalAgencySecurities
53729000000 usd
CY2023Q4 agnc Total Agency Securities
TotalAgencySecurities
53794000000 usd
CY2024Q1 agnc Debt Securities Tradingand Availableforsale Amortized Cost Basis
DebtSecuritiesTradingandAvailableforsaleAmortizedCostBasis
57464000000 usd
CY2024Q1 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
54776000000 usd
CY2023Q4 agnc Debt Securities Tradingand Availableforsale Amortized Cost Basis
DebtSecuritiesTradingandAvailableforsaleAmortizedCostBasis
56965000000 usd
CY2023Q4 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
54824000000 usd
CY2024Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
50190000000 usd
CY2024Q1 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
54776000000 usd
CY2024Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0493
CY2024Q1 agnc Weighted Average Yield Percentage
WeightedAverageYieldPercentage
0.0452
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
50008000000 usd
CY2023Q4 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
54824000000 usd
CY2024Q1 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
59000000 usd
CY2023Q4 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
44000000 usd
CY2024Q1 agnc Future Prepayment Rate Assumption Of Investment Portfolio
FuturePrepaymentRateAssumptionOfInvestmentPortfolio
0.104
agnc Future Prepayment Rate Assumption Of Investment Portfolio
FuturePrepaymentRateAssumptionOfInvestmentPortfolio
0.114
CY2024Q1 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
59000000 usd
CY2023Q4 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
44000000 usd
CY2024Q1 agnc Future Prepayment Rate Assumption Of Investment Portfolio
FuturePrepaymentRateAssumptionOfInvestmentPortfolio
0.104
agnc Future Prepayment Rate Assumption Of Investment Portfolio
FuturePrepaymentRateAssumptionOfInvestmentPortfolio
0.114
CY2024Q1 agnc Available For Sale Securities Weighted Average Life Fair Value
AvailableForSaleSecuritiesWeightedAverageLifeFairValue
54776000000 usd
CY2024Q1 agnc Available For Sale Securities Weighted Average Life Amortized Cost
AvailableForSaleSecuritiesWeightedAverageLifeAmortizedCost
57464000000 usd
CY2024Q1 agnc Available For Sale Securities Weighted Average Life Coupon Rate
AvailableForSaleSecuritiesWeightedAverageLifeCouponRate
0.0493
CY2024Q1 agnc Available For Sale Securities Weighted Average Life Yield
AvailableForSaleSecuritiesWeightedAverageLifeYield
0.0452
CY2023Q4 agnc Available For Sale Securities Weighted Average Life Fair Value
AvailableForSaleSecuritiesWeightedAverageLifeFairValue
54824000000 usd
CY2023Q4 agnc Available For Sale Securities Weighted Average Life Amortized Cost
AvailableForSaleSecuritiesWeightedAverageLifeAmortizedCost
56965000000 usd
CY2024Q1 agnc Costof Saleof Fair Value Option Securities
CostofSaleofFairValueOptionSecurities
5218000000 usd
CY2024Q1 agnc Costof Saleof Investment Securities
CostofSaleofInvestmentSecurities
5218000000 usd
CY2023Q1 agnc Costof Saleof Fair Value Option Securities
CostofSaleofFairValueOptionSecurities
1672000000 usd
CY2023Q1 agnc Costof Saleof Investment Securities
CostofSaleofInvestmentSecurities
1874000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2024Q1 agnc Proceeds From Sale Of Debt Securities Trading
ProceedsFromSaleOfDebtSecuritiesTrading
5127000000 usd
CY2024Q1 agnc Proceeds From Sale Of Debt Securities
ProceedsFromSaleOfDebtSecurities
5127000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
178000000 usd
CY2023Q1 agnc Proceeds From Sale Of Debt Securities Trading
ProceedsFromSaleOfDebtSecuritiesTrading
1615000000 usd
CY2023Q1 agnc Proceeds From Sale Of Debt Securities
ProceedsFromSaleOfDebtSecurities
1793000000 usd
CY2024Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-91000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
-81000000 usd
CY2024Q1 agnc Principal Payments Received On Available For Sale Securities
PrincipalPaymentsReceivedOnAvailableForSaleSecurities
143000000 usd
CY2023Q1 agnc Principal Payments Received On Available For Sale Securities
PrincipalPaymentsReceivedOnAvailableForSaleSecurities
179000000 usd
CY2024Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
50000000000 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
50400000000 usd
CY2024Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
49971000000 usd
CY2024Q1 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.0546
CY2024Q1 agnc Repurchase Agreements Weighted Average Days To Maturity
RepurchaseAgreementsWeightedAverageDaysToMaturity
21 days
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
50426000000 usd
CY2023Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.0560
CY2023Q4 agnc Repurchase Agreements Weighted Average Days To Maturity
RepurchaseAgreementsWeightedAverageDaysToMaturity
19 days
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
84000000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
185000000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
65000000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
362000000 usd
CY2024Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1836000000 usd
CY2023Q4 us-gaap Financial Instruments Sold Not Yet Purchased Us Government And Agency Obligations
FinancialInstrumentsSoldNotYetPurchasedUSGovernmentAndAgencyObligations
10894000000 usd
CY2024Q1 agnc Governmentbondsownedandsoldshortnet
Governmentbondsownedandsoldshortnet
-10279000000 usd
CY2023Q4 agnc Governmentbondsownedandsoldshortnet
Governmentbondsownedandsoldshortnet
-9354000000 usd
CY2024Q1 agnc Net Fair Value Of Interest Rate Swaps Excluding The Recognition Of Variation Margin Settlements As A Reduction Of Carrying Value
NetFairValueOfInterestRateSwapsExcludingTheRecognitionOfVariationMarginSettlementsAsAReductionOfCarryingValue
3000000000 usd
CY2023Q4 agnc Net Fair Value Of Interest Rate Swaps Excluding The Recognition Of Variation Margin Settlements As A Reduction Of Carrying Value
NetFairValueOfInterestRateSwapsExcludingTheRecognitionOfVariationMarginSettlementsAsAReductionOfCarryingValue
2900000000 usd
CY2024Q1 agnc Interest Rate Swaps Linkedto Secured Overnight Financing Rate
InterestRateSwapsLinkedtoSecuredOvernightFinancingRate
0.80
CY2024Q1 agnc Interest Rate Swaps Linkedto Overnight Index Swap Rate
InterestRateSwapsLinkedtoOvernightIndexSwapRate
0.20
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1102000000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-506000000 usd
CY2024Q1 agnc Risk Of Repurchase Agreement To Stockholders Equity
RiskOfRepurchaseAgreementToStockholdersEquity
0.03
CY2024Q1 agnc Available For Sale Securities Pledged As Collateral Accrued Interest
AvailableForSaleSecuritiesPledgedAsCollateralAccruedInterest
230000000 usd
CY2024Q1 agnc Total Fair Valueof Securities Pledgedand Accrued Interest
TotalFairValueofSecuritiesPledgedandAccruedInterest
53009000000 usd
CY2023Q4 agnc Available For Sale Securities Pledged As Collateral Accrued Interest
AvailableForSaleSecuritiesPledgedAsCollateralAccruedInterest
217000000 usd
CY2023Q4 agnc Total Fair Value Of Agency Securities Pledged And Accrued Interest
TotalFairValueOfAgencySecuritiesPledgedAndAccruedInterest
54075000000 usd
CY2024Q1 agnc Retained Interestsin Consolidated Vi Es Pledgedas Collateral Under Repurchase Agreements
RetainedInterestsinConsolidatedVIEsPledgedasCollateralUnderRepurchaseAgreements
39000000 usd
CY2023Q4 agnc Retained Interestsin Consolidated Vi Es Pledgedas Collateral Under Repurchase Agreements
RetainedInterestsinConsolidatedVIEsPledgedasCollateralUnderRepurchaseAgreements
42000000 usd
CY2024Q1 agnc Securities Owned And Pledged As Collateral Fair Value
SecuritiesOwnedAndPledgedAsCollateralFairValue
51225000000 usd
CY2024Q1 agnc Agency Securities Pledged As Collateral Amortized Cost
AgencySecuritiesPledgedAsCollateralAmortizedCost
53643000000 usd
CY2024Q1 agnc Agency Securities Pledged As Collateral Accrued Interest
AgencySecuritiesPledgedAsCollateralAccruedInterest
230000000 usd
CY2023Q4 agnc Securities Owned And Pledged As Collateral Fair Value
SecuritiesOwnedAndPledgedAsCollateralFairValue
52072000000 usd
CY2023Q4 agnc Agency Securities Pledged As Collateral Amortized Cost
AgencySecuritiesPledgedAsCollateralAmortizedCost
53934000000 usd
CY2023Q4 agnc Agency Securities Pledged As Collateral Accrued Interest
AgencySecuritiesPledgedAsCollateralAccruedInterest
217000000 usd
CY2024Q1 agnc Retained Interestsin Consolidated Vi Es Pledgedas Collateral Under Repurchase Agreements
RetainedInterestsinConsolidatedVIEsPledgedasCollateralUnderRepurchaseAgreements
39000000 usd
CY2023Q4 agnc Retained Interestsin Consolidated Vi Es Pledgedas Collateral Under Repurchase Agreements
RetainedInterestsinConsolidatedVIEsPledgedasCollateralUnderRepurchaseAgreements
42000000 usd
CY2024Q1 agnc Gross Amountsof Cash Collateral Not Offsetonthe Balance Sheet
GrossAmountsofCashCollateralNotOffsetontheBalanceSheet
3746000000 usd
CY2024Q1 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
53615000000 usd
CY2023Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
53673000000 usd
CY2024Q1 agnc Agencysecuritiestransferredtoconsolidatedvariableinterestentitiesatfairvalue
Agencysecuritiestransferredtoconsolidatedvariableinterestentitiesatfairvalue
114000000 usd
CY2023Q4 agnc Agencysecuritiestransferredtoconsolidatedvariableinterestentitiesatfairvalue
Agencysecuritiestransferredtoconsolidatedvariableinterestentitiesatfairvalue
121000000 usd
CY2024Q1 us-gaap Financial Instruments Owned Other At Fair Value
FinancialInstrumentsOwnedOtherAtFairValue
753000000 usd
CY2023Q4 us-gaap Financial Instruments Owned Other At Fair Value
FinancialInstrumentsOwnedOtherAtFairValue
723000000 usd
CY2024Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1836000000 usd
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1540000000 usd
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
76000000 usd
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
80000000 usd
CY2024Q1 agnc Obligation To Return Securities Borrowed Under Reverse Repurchase Agreements At Fair Value
ObligationToReturnSecuritiesBorrowedUnderReverseRepurchaseAgreementsAtFairValue
12115000000 usd
CY2023Q4 agnc Obligation To Return Securities Borrowed Under Reverse Repurchase Agreements At Fair Value
ObligationToReturnSecuritiesBorrowedUnderReverseRepurchaseAgreementsAtFairValue
10894000000 usd
CY2024Q1 agnc Net Fair Value Of Interest Rate Swaps Excluding The Recognition Of Variation Margin Settlements As A Reduction Of Carrying Value
NetFairValueOfInterestRateSwapsExcludingTheRecognitionOfVariationMarginSettlementsAsAReductionOfCarryingValue
3000000000 usd
CY2023Q4 agnc Net Fair Value Of Interest Rate Swaps Excluding The Recognition Of Variation Margin Settlements As A Reduction Of Carrying Value
NetFairValueOfInterestRateSwapsExcludingTheRecognitionOfVariationMarginSettlementsAsAReductionOfCarryingValue
2900000000 usd
CY2024Q1 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
59000000 usd
CY2023Q4 agnc Mortgage Credit Investment Fund Limited Partnership
MortgageCreditInvestmentFundLimitedPartnership
44000000 usd
CY2024Q1 agnc Weighted Average Numberof Shares Outstanding
WeightedAverageNumberofSharesOutstanding
700100000 shares
CY2023Q1 agnc Weighted Average Numberof Shares Outstanding
WeightedAverageNumberofSharesOutstanding
577600000 shares
CY2024Q1 agnc Weighted Average Numberof Fully Vested Restricted Stock Unitsand Performance Share Units Outstanding
WeightedAverageNumberofFullyVestedRestrictedStockUnitsandPerformanceShareUnitsOutstanding
2100000 shares
CY2023Q1 agnc Weighted Average Numberof Fully Vested Restricted Stock Unitsand Performance Share Units Outstanding
WeightedAverageNumberofFullyVestedRestrictedStockUnitsandPerformanceShareUnitsOutstanding
1700000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
702200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
579300000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000.0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
704200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
579300000 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
412000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-181000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 agnc Preferred Stock C Value Issued
PreferredStockCValueIssued
315000000 usd
CY2024Q1 agnc Preferred Stock C Liquidation Preference Value
PreferredStockCLiquidationPreferenceValue
325000000 usd
CY2024Q1 agnc Preferred Stock D Value Issued
PreferredStockDValueIssued
227000000 usd
CY2024Q1 agnc Preferred Stock D Liquidation Preference Value
PreferredStockDLiquidationPreferenceValue
235000000 usd
CY2019Q4 agnc Preferred Stock E Value Issued
PreferredStockEValueIssued
390000000 usd
CY2019Q4 agnc Preferred Stock E Liquidation Preference Value
PreferredStockELiquidationPreferenceValue
403000000 usd
CY2020Q1 agnc Preferred Stock F Value Issued
PreferredStockFValueIssued
557000000 usd
CY2022Q3 agnc Preferred Stock G Value Issued
PreferredStockGValueIssued
145000000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
1634000000 usd
CY2024Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
1688000000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25100000 shares
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
241000000 usd
CY2024Q1 agnc Stock Issued During Period Price Per Share
StockIssuedDuringPeriodPricePerShare
9.61
CY2024Q1 agnc Commonstock Valueof Shares Remainingfor Future Issuance
CommonstockValueofSharesRemainingforFutureIssuance
600000000 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
agnc-20240331_cal.xml Edgar Link unprocessable
0001423689-24-000039-index-headers.html Edgar Link pending
0001423689-24-000039-index.html Edgar Link pending
0001423689-24-000039.txt Edgar Link pending
0001423689-24-000039-xbrl.zip Edgar Link pending
agnc-20240331.htm Edgar Link pending
agnc-20240331.xsd Edgar Link pending
agnc-20240331_g1.jpg Edgar Link pending
agncexhibit103312410-q.htm Edgar Link pending
agncexhibit3113312410-q.htm Edgar Link pending
agncexhibit3123312410-q.htm Edgar Link pending
agncexhibit323312410-q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
agnc-20240331_lab.xml Edgar Link unprocessable
agnc-20240331_pre.xml Edgar Link unprocessable
agnc-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
agnc-20240331_def.xml Edgar Link unprocessable